drugset / Trial / NCT01236768
Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of the study is to evaluate the efficacy and safety of a low dose transdermal contraceptive delivery system containing ethinyl estradiol and levonorgestrel.
Timeline
- Start
- 2010-10
- Primary completion
- 2011-06
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AG200-15 | Unknown | — | Other |
| Comparator | Orlistat | Small molecule | 30 ug | Oral |
| Comparator | Orlistat | Small molecule | 150 ug | Oral |
Indications
No indication recorded.